Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials
click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate



Showing posts with label Epidemiology. Show all posts
Showing posts with label Epidemiology. Show all posts

Saturday, January 10, 2015

India: HCV infection in hemodialysis patients raises concerns

AURANGABAD: Hepatitis C virus (HCV) infection which is an important pathogen causing liver disease is becoming a major public health problem, with an estimated 25% to 40% prevalence in India. Raising concern over the issue, experts said patients on multiple blood transfusions have a high risk for HCV due to the involvement of multiple routes of infections, especially poor blood screening of blood and low standard of dialysis procedures.

They were speaking at a workshop at Dattaji Bhale blood bank, organised by the Aurangabad Thalassemia Society to create awareness about thalassemia on Friday.

Mahendrasingh H Chauhan, medical director and in charge of the blood bank said that high prevalence of Hepatitis C virus (HCV) has been reported among dialysis patients throughout the world. Serious efforts need to be taken to investigate HCV in patients undergoing hemodialysis (HD) treatment who are at great risk to HCV infection.

Read more...

Friday, January 2, 2015

Canada: B.C. medical researchers offer treatment by prevention for hepatitis C

Innovation: While stressing there is still work to be done when it comes to fighting HIV/AIDS – other provinces have not seen the same progress as B.C., and rates remain high in some First Nations communities – Dr. Montaner said one area he is watching is treatment of hepatitis C.

“I think one of the most exciting developments that is happening is the emergence of new treatment – highly effective, very simple, extremely well tolerated, but unfortunately very expensive – for hepatitis C.” - Julio Montaner, director of the B.C. Centre for Excellence in HIV/AIDS

Mel Krajden, medical head of hepatitis – clinical prevention services at the B.C. Centre for Disease Control, said between 70,000 and 80,000 British Columbians have hepatitis C, a chronic liver disease.